Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice (original) (raw)

Abstract

The hepatitis B virus X protein acts as a transcriptional transactivator in vitro. To elucidate possible biological effects of X protein on liver cells in vivo, we generated four lines of transgenic mice carrying the X gene open reading frame under the control of the human alpha-1-antitrypsin regulatory region. The plasmid construct used to introduce the transgene was shown to encode a 16-kDa X protein with transactivating capability. The expression of X protein was detectable in liver tissue of transgenic animals of three of the lines by immunoblot analysis; levels of expression were highest in the first month after birth of the animals. Over 80 animals from the expressing lines were examined histologically. Most transgenic mice, some of which were observed for up to 2 years, remained normal. However, a few transgenic animals developed mild focal hepatitis, nuclear pleomorphism, focal necrosis, and/or nodular hyperplasia in the liver. Increased mitotic activity of hepatocytes also was observed. We conclude that, at the level of expression achieved in these transgenic mice, the hepatitis B virus transcriptional transactivator X protein alone does not appear to mediate the development of serious liver damage or hepatocellular carcinomas.

5939

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979 Dec 6;282(5739):615–616. doi: 10.1038/282615a0. [DOI] [PubMed] [Google Scholar]
  2. Araki K., Miyazaki J., Hino O., Tomita N., Chisaka O., Matsubara K., Yamamura K. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A. 1989 Jan;86(1):207–211. doi: 10.1073/pnas.86.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aufiero B., Schneider R. J. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 1990 Feb;9(2):497–504. doi: 10.1002/j.1460-2075.1990.tb08136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Babinet C., Farza H., Morello D., Hadchouel M., Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science. 1985 Dec 6;230(4730):1160–1163. doi: 10.1126/science.3865370. [DOI] [PubMed] [Google Scholar]
  5. Brinster R. L., Chen H. Y., Messing A., van Dyke T., Levine A. J., Palmiter R. D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell. 1984 Jun;37(2):367–379. doi: 10.1016/0092-8674(84)90367-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buetow K. H., Murray J. C., Israel J. L., London W. T., Smith M., Kew M., Blanquet V., Brechot C., Redeker A., Govindarajah S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8852–8856. doi: 10.1073/pnas.86.22.8852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burk R. D., DeLoia J. A., elAwady M. K., Gearhart J. D. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol. 1988 Feb;62(2):649–654. doi: 10.1128/jvi.62.2.649-654.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carlson J. A., Rogers B. B., Sifers R. N., Hawkins H. K., Finegold M. J., Woo S. L. Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest. 1988 Jul;82(1):26–36. doi: 10.1172/JCI113580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  10. Chisaka O., Araki K., Ochiya T., Tsurimoto T., Hiranyawasitte-Attatippaholkun W., Yanaihara N., Matsubara K. Purification of hepatitis B virus gene X product synthesized in Escherichia coli and its detection in a human hepatoblastoma cell line producing hepatitis B virus. Gene. 1987;60(2-3):183–189. doi: 10.1016/0378-1119(87)90226-5. [DOI] [PubMed] [Google Scholar]
  11. Chisari F. V., Filippi P., Buras J., McLachlan A., Popper H., Pinkert C. A., Palmiter R. D., Brinster R. L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6909–6913. doi: 10.1073/pnas.84.19.6909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989 Dec 22;59(6):1145–1156. doi: 10.1016/0092-8674(89)90770-8. [DOI] [PubMed] [Google Scholar]
  13. Chisari F. V., Pinkert C. A., Milich D. R., Filippi P., McLachlan A., Palmiter R. D., Brinster R. L. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science. 1985 Dec 6;230(4730):1157–1160. doi: 10.1126/science.3865369. [DOI] [PubMed] [Google Scholar]
  14. Colgrove R., Simon G., Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol. 1989 Sep;63(9):4019–4026. doi: 10.1128/jvi.63.9.4019-4026.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cuthbertson R. A., Klintworth G. K. Transgenic mice--a gold mine for furthering knowledge in pathobiology. Lab Invest. 1988 May;58(5):484–502. [PubMed] [Google Scholar]
  16. DeLoia J. A., Burk R. D., Gearhart J. D. Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J Virol. 1989 Sep;63(9):4069–4073. doi: 10.1128/jvi.63.9.4069-4073.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Farza H., Salmon A. M., Hadchouel M., Moreau J. L., Babinet C., Tiollais P., Pourcel C. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1187–1191. doi: 10.1073/pnas.84.5.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Feitelson M. A., Clayton M. M. X antigen polypeptides in the sera of hepatitis B virus-infected patients. Virology. 1990 Jul;177(1):367–371. doi: 10.1016/0042-6822(90)90492-a. [DOI] [PubMed] [Google Scholar]
  19. Ganem D., Varmus H. E. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 1987;56:651–693. doi: 10.1146/annurev.bi.56.070187.003251. [DOI] [PubMed] [Google Scholar]
  20. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hanahan D. Transgenic mice as probes into complex systems. Science. 1989 Dec 8;246(4935):1265–1275. doi: 10.1126/science.2686032. [DOI] [PubMed] [Google Scholar]
  22. Jarvis D. L., Butel J. S. Modification of simian virus 40 large tumor antigen by glycosylation. Virology. 1985 Mar;141(2):173–189. doi: 10.1016/0042-6822(85)90250-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Katayama K., Hayashi N., Sasaki Y., Kasahara A., Ueda K., Fusamoto H., Sato N., Chisaka O., Matsubara K., Kamada T. Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology. 1989 Oct;97(4):990–998. doi: 10.1016/0016-5085(89)91508-4. [DOI] [PubMed] [Google Scholar]
  24. Kay A., Mandart E., Trepo C., Galibert F. The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J. 1985 May;4(5):1287–1292. doi: 10.1002/j.1460-2075.1985.tb03774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Koike K., Akatsuka T., Miyamura T. Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology. 1988 Mar;163(1):233–235. doi: 10.1016/0042-6822(88)90256-5. [DOI] [PubMed] [Google Scholar]
  26. Lanford R. E., Butel J. S. Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology. 1979 Sep;97(2):295–306. doi: 10.1016/0042-6822(79)90341-6. [DOI] [PubMed] [Google Scholar]
  27. Liang X. H., Stemler M., Will H., Braun R., Tang Z. Y., Schröder C. H. Low incidence and high titers of antibodies to hepatitis B virus X-protein in sera of Chinese patients with hepatocellular carcinoma. J Med Virol. 1988 Jul;25(3):329–337. doi: 10.1002/jmv.1890250310. [DOI] [PubMed] [Google Scholar]
  28. Meyers M. L., Trepo L. V., Nath N., Sninsky J. J. Hepatitis B virus polypeptide X: expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans. J Virol. 1986 Jan;57(1):101–109. doi: 10.1128/jvi.57.1.101-109.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moriarty A. M., Alexander H., Lerner R. A., Thornton G. B. Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science. 1985 Jan 25;227(4685):429–433. doi: 10.1126/science.2981434. [DOI] [PubMed] [Google Scholar]
  30. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science. 1987 Sep 11;237(4820):1324–1329. doi: 10.1126/science.2888190. [DOI] [PubMed] [Google Scholar]
  31. Pfaff E., Salfeld J., Gmelin K., Schaller H., Theilmann L. Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology. 1987 Jun;158(2):456–460. doi: 10.1016/0042-6822(87)90221-2. [DOI] [PubMed] [Google Scholar]
  32. Pourcel C., Tiollais P., Farza H. Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity. J Virol. 1990 Feb;64(2):931–935. doi: 10.1128/jvi.64.2.931-935.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pugh J. C., Weber C., Houston H., Murray K. Expression of the X gene of hepatitis B virus. J Med Virol. 1986 Nov;20(3):229–246. doi: 10.1002/jmv.1890200305. [DOI] [PubMed] [Google Scholar]
  34. Sepulveda A. R., Finegold M. J., Smith B., Slagle B. L., DeMayo J. L., Shen R. F., Woo S. L., Butel J. S. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res. 1989 Nov 1;49(21):6108–6117. [PubMed] [Google Scholar]
  35. Seto E., Mitchell P. J., Yen T. S. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature. 1990 Mar 1;344(6261):72–74. doi: 10.1038/344072a0. [DOI] [PubMed] [Google Scholar]
  36. Seto E., Yen T. S., Peterlin B. M., Ou J. H. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8286–8290. doi: 10.1073/pnas.85.21.8286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Seto E., Zhou D. X., Peterlin B. M., Yen T. S. trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology. 1989 Dec;173(2):764–766. doi: 10.1016/0042-6822(89)90594-1. [DOI] [PubMed] [Google Scholar]
  38. Shen R. F., Clift S. M., DeMayo J. L., Sifers R. N., Finegold M. J., Woo S. L. Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice. DNA. 1989 Mar;8(2):101–108. doi: 10.1089/dna.1.1989.8.101. [DOI] [PubMed] [Google Scholar]
  39. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res. 1989 Jul;80(7):617–621. doi: 10.1111/j.1349-7006.1989.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Siddiqui A., Jameel S., Mapoles J. Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2513–2517. doi: 10.1073/pnas.84.8.2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Siddiqui A., Marion P. L., Robinson W. S. Ground squirrel hepatitis virus DNA: molecular cloning and comparison with hepatitis B virus DNA. J Virol. 1981 Apr;38(1):393–397. doi: 10.1128/jvi.38.1.393-397.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sifers R. N., Carlson J. A., Clift S. M., DeMayo F. J., Bullock D. W., Woo S. L. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res. 1987 Feb 25;15(4):1459–1475. doi: 10.1093/nar/15.4.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Slagle B. L., Lanford R. E., Medina D., Butel J. S. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Cancer Res. 1984 May;44(5):2155–2162. [PubMed] [Google Scholar]
  44. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  45. Spandau D. F., Lee C. H. trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 1988 Feb;62(2):427–434. doi: 10.1128/jvi.62.2.427-434.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 1985 Oct 10;317(6037):489–495. doi: 10.1038/317489a0. [DOI] [PubMed] [Google Scholar]
  47. Twu J. S., Robinson W. S. Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2046–2050. doi: 10.1073/pnas.86.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Twu J. S., Schloemer R. H. Transcriptional trans-activating function of hepatitis B virus. J Virol. 1987 Nov;61(11):3448–3453. doi: 10.1128/jvi.61.11.3448-3453.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Unger T., Shaul Y. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J. 1990 Jun;9(6):1889–1895. doi: 10.1002/j.1460-2075.1990.tb08315.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 1988 Oct 13;335(6191):606–611. doi: 10.1038/335606a0. [DOI] [PubMed] [Google Scholar]
  51. Wang H. P., Rogler C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet. 1988;48(2):72–78. doi: 10.1159/000132593. [DOI] [PubMed] [Google Scholar]
  52. Wang J., Chenivesse X., Henglein B., Bréchot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 1990 Feb 8;343(6258):555–557. doi: 10.1038/343555a0. [DOI] [PubMed] [Google Scholar]
  53. Zahm P., Hofschneider P. H., Koshy R. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene. 1988 Aug;3(2):169–177. [PubMed] [Google Scholar]
  54. Zentgraf H., Herrmann G., Klein R., Schranz P., Loncarevic I., Herrmann D., Hübner K., Schröder C. H. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology. 1990;47(2):143–148. doi: 10.1159/000226807. [DOI] [PubMed] [Google Scholar]
  55. Zhou Y. Z., Slagle B. L., Donehower L. A., vanTuinen P., Ledbetter D. H., Butel J. S. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol. 1988 Nov;62(11):4224–4231. doi: 10.1128/jvi.62.11.4224-4231.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]